These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 1691547)

  • 1. Pancreatic juice neopterin excretion--reliable marker for detection of pancreatic allograft rejection.
    Königsrainer A; Reibnegger G; Ofner D; Klima G; Tauscher T; Margreiter R
    Transplant Proc; 1990 Apr; 22(2):671-2. PubMed ID: 1691547
    [No Abstract]   [Full Text] [Related]  

  • 2. Pancreatic juice neopterin excretion--a reliable marker of pancreas allograft rejection.
    Königsrainer A; Tilg H; Reibnegger G; Steurer W; Schmid T; Wachter H; Margreiter R
    Transplant Proc; 1992 Jun; 24(3):907-8. PubMed ID: 1604663
    [No Abstract]   [Full Text] [Related]  

  • 3. Rejection of kidney and pancreas after pancreas-kidney transplantation.
    Margreiter R; Klima G; Bösmüller C; Königsrainer A; Schmid T; Steiner E
    Diabetes; 1989 Jan; 38 Suppl 1():79-81. PubMed ID: 2463201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring of the pancreatic allograft by analysis of exocrine secretion.
    Steiner E; Klima G; Niederwieser D; Königsrainer A; Herold M; Margreiter R
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2336-8. PubMed ID: 3547929
    [No Abstract]   [Full Text] [Related]  

  • 5. Pancreatic juice immunoreactive thromboxane B2 in pancreas allograft rejection.
    Nakache R; Granstrom E; Brattstrom C; Tyden G; Groth CG
    Transplant Proc; 1990 Apr; 22(2):669. PubMed ID: 1691546
    [No Abstract]   [Full Text] [Related]  

  • 6. Markers for pancreas-graft rejection in humans.
    Brattström C; Tydén G; Reinholt FP; Bohman SO; Borgström A; Bäckman L; Bolinder J; Groth CG
    Diabetes; 1989 Jan; 38 Suppl 1():57-62. PubMed ID: 2463197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring the response to anti-rejection therapy with serum neopterin.
    Smillie AE; Rigby RJ; Petrie JJ
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1869-70. PubMed ID: 2652608
    [No Abstract]   [Full Text] [Related]  

  • 8. Possibility of recognizing immunologic and cyclosporine A damage by urinary neopterin excretion in kidney transplant recipients.
    Magalini SC; Nanni G; Sambo A; Agnes S; Luciani G; Pozzetto A; Avolio A; Cittadini A; Castagneto M
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1686-8. PubMed ID: 3274405
    [No Abstract]   [Full Text] [Related]  

  • 9. Diagnosis of pancreatic graft rejection by pancreatic juice cytology.
    Tydén G; Reinholt F; Bohman SO; Brattström C; Tibell A; Groth CG
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2780-1. PubMed ID: 2468237
    [No Abstract]   [Full Text] [Related]  

  • 10. Monitoring of the serum neopterin/creatinine ratio in renal transplantation.
    Hacini D; Guerin C; Berthoux P; Ville G; Berthoux F
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2185-6. PubMed ID: 3274488
    [No Abstract]   [Full Text] [Related]  

  • 11. Urinary and pancreatic juice neopterin excretion after combined pancreas-kidney transplantation.
    Tilg H; Königsrainer A; Krausler R; Aulitzky WE; Margreiter R; Reibnegger G; Wachter H; Huber C
    Transplantation; 1992 Apr; 53(4):804-8. PubMed ID: 1314440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring of heart allograft rejection by simultaneous measurement of serum beta 2-microglobulin and urinary neopterin.
    Schmitt F; Myara I; Benoit MO; Guillemain R; Amrein C; Dreyfus G; Paris M; Moatti N
    Ann Biol Clin (Paris); 1989; 47(5):237-41. PubMed ID: 2662838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis of rejection in recipients of pancreatic grafts with enteric exocrine diversion by monitoring pancreatic juice cytology and amylase excretion.
    Tydén G; Reinholt F; Brattström C; Lundgren G; Wilczek H; Bolinder J; Ostman J; Groth CG
    Transplant Proc; 1987 Oct; 19(5):3892-4. PubMed ID: 2445060
    [No Abstract]   [Full Text] [Related]  

  • 14. Analysis of the rejection markers tumor necrosis factor, ICAM-1, neopterin, interleukin-10, and soluble HLA in simultaneous pancreas and kidney transplantation with bladder drainage.
    Abendroth D; Storck M; Techt B; Zavazava N
    Transplant Proc; 1995 Dec; 27(6):3114-5. PubMed ID: 8539869
    [No Abstract]   [Full Text] [Related]  

  • 15. Cytologic patterns in juice from human pancreatic transplants: correlation with histologic findings in the graft.
    Kubota K; Reinholt FP; Tydén G; Bohman SO; Groth CG
    Surgery; 1991 Apr; 109(4):507-14. PubMed ID: 1706893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Markers for pancreatic allograft rejection: comparison of serum anodal trypsinogen, serum amylase, serum creatinine and urinary amylase.
    Douzdjian V; Cooper JL; Abecassis MM; Corry RJ
    Clin Transplant; 1994 Apr; 8(2 Pt 1):79-82. PubMed ID: 7517225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated tumor necrosis factor levels are predictive for pancreas allograft transplant rejection.
    Grewal HP; Kotb M; Salem A; el Din AB; Novak K; Martin J; Gaber LW; Gaber AO
    Transplant Proc; 1993 Feb; 25(1 Pt 1):132-5. PubMed ID: 7679807
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of serum neopterin levels and urinary neopterin excretion in renal allograft recipients.
    Aulitzky WE; Tilg H; Niederwieser D; Riccabona G; Obendorf L; Margreiter R; Pfaller W; Huber C
    Clin Nephrol; 1988 May; 29(5):248-52. PubMed ID: 3293855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neopterin changes after clinical heart transplantation.
    Wang SS; Chu SH; Ko WJ
    Transplant Proc; 1996 Jun; 28(3):1730-2. PubMed ID: 8658860
    [No Abstract]   [Full Text] [Related]  

  • 20. Recent experience with pancreatic juice cytology in monitoring pancreatic graft rejection.
    Kubota K; Reinholt FP; Tydén G; Groth CG
    Transplant Proc; 1989 Aug; 21(4):3643-5. PubMed ID: 2669271
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.